Cargando…

Loss of Fas expression and high expression of HLA-E promoting the immune escape of early colorectal cancer cells

Previous studies have investigated the mechanisms of immune evasion of tumor cells in numerous types of advanced solid malignant tumor, and several types of immune preparations have been administered as antitumor adjuvant therapies. However, in the majority of studies, the efficacy of therapies has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Renxiang, Zhang, Dongyang, Li, Feng, Xiao, Zili, Wu, Meiling, Shi, Dongyun, Xiang, Ping, Bao, Zhijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431327/ https://www.ncbi.nlm.nih.gov/pubmed/28521443 http://dx.doi.org/10.3892/ol.2017.5891

Ejemplares similares

Fas and Fas ligand are highly expressed in lymphocytes from cervical intraepithelial neoplasia and cervical cancer patients: A possible role for immune escaping
por: Contreras-Ochoa, Carla O., et al.
Publicado: (2022)

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
por: McGranahan, Nicholas, et al.
Publicado: (2017)

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape
por: Perea, Francisco, et al.
Publicado: (2017)

HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
por: Gornalusse, Germán G., et al.
Publicado: (2017)

Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma
por: Butler, L M, et al.
Publicado: (2000)

Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma
por: Fangazio, Marco, et al.
Publicado: (2021)

The immune phenotypes and different immune escape mechanisms in colorectal cancer
por: Mao, Yihao, et al.
Publicado: (2022)

Fas Ligand Expression in Lynch Syndrome-Associated Colorectal Tumours
por: Koornstra, Jan J., et al.
Publicado: (2008)

Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes
por: Gil-Julio, Hernani, et al.
Publicado: (2021)

Differential expressions of Fas and Fas ligand in human placenta.
por: Roh, Cheong-Rae, et al.
Publicado: (2002)

The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture
por: Garrido, Federico, et al.
Publicado: (2017)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis
por: Benevolo, Maria, et al.
Publicado: (2011)

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2000)

Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients.
por: Hamzaoui, Agnès, et al.
Publicado: (2003)

Expression Profile of Fas-Fas Ligand in Spiral Ganglion Cells During Apoptosis
por: Gu, Tae Woo, et al.
Publicado: (2014)

Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer
por: Westcott, Peter M K, et al.
Publicado: (2021)

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma
por: Schäfer, Helene, et al.
Publicado: (2023)

The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells
por: Liu, Lu, et al.
Publicado: (2020)

Fas expression is downregulated in gastric cancer
por: Wang, Xuming, et al.
Publicado: (2017)

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation
por: Perabo, F G E, et al.
Publicado: (2001)

Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
por: Saranchova, Iryna, et al.
Publicado: (2016)

Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids
Publicado: (1995)

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?
por: Nijland, Marcel, et al.
Publicado: (2017)

The Immune Escape Mechanisms of Mycobacterium Tuberculosis
por: Zhai, Weijie, et al.
Publicado: (2019)

Human cytomegalovirus suppresses Fas expression and function
por: Seirafian, Sepehr, et al.
Publicado: (2014)

Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens
por: Flores-Mendoza, Giovanna, et al.
Publicado: (2021)

Plasma Levels of sFas-sFasL and FASL Gene Expression Are Associated with Tuberculosis
por: Souza, Iury de Paula, et al.
Publicado: (2022)

Soluble HLA Class I Molecules/CD8 Ligation Trigger Apoptosis of CD8 Cells by Fas/Fas-Ligand Interaction
por: Puppo, Francesco, et al.
Publicado: (2002)

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
por: LÃ³pez-Nevot, M. A., et al.
Publicado: (1989)

Revisiting immune escape in colorectal cancer in the era of immunotherapy
por: Ijsselsteijn, Marieke Erica, et al.
Publicado: (2019)

Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation
por: Minas, V, et al.
Publicado: (2007)

Akt and SHIP Modulate Francisella Escape from the Phagosome and Induction of the Fas-Mediated Death Pathway
por: Rajaram, Murugesan V. S., et al.
Publicado: (2009)

Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement.
por: Butler, L. M., et al.
Publicado: (1998)

Different methods of detaching adherent cells and their effects on the cell surface expression of Fas receptor and Fas ligand
por: Lai, Ting-Yu, et al.
Publicado: (2022)

FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas
por: Mann, B, et al.
Publicado: (1999)

HLA-G Expressing Immune Cells in Immune Mediated Diseases
por: Contini, P., et al.
Publicado: (2020)

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
Publicado: (1996)

Disruption of Fas-Fas Ligand Signaling, Apoptosis, and Innate Immunity by Bacterial Pathogens
por: Caulfield, Adam J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7j2penjvvekdc7opf2gu4dlhvu